Inhibition of inducible NO synthase by TH2 cytokines and TGFβ in rheumatoid arthritic synoviocytes: Effects on nitrosothiol production

Nitric Oxide - Biology and Chemistry

Volumn 6, Issue 3, 2002, Pages 271-282

  Borderie, Didier ^a   Hilliquin, Pascal ^a   Hernvann, Alain ^a   Lemarechal, Hervé ^a   Kahan, André ^a   Menkes, Charles J ^a   Ekindjian, Ohvanesse G ^a  

^a Université Paris v ^*  (France)

Author keywords

Cytokines; Nitric oxide; Nitrosothiols; Rheumatoid arthritis; Synovial cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; NITRIC OXIDE SYNTHASE; NITRITE; NITROSO DERIVATIVE; S NITROSOTHIOL DERIVATIVE; THIOL DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; ENZYME INHIBITION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; IMMUNOFLUORESCENCE; MALE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; SYNOVIOCYTE; TH2 CELL;

EID: 0036334658     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1006/niox.2001.0418     Document Type: Article

References (57)

1. Molecular and cellular mechanisms of joint destruction: Two cellular mechanisms explain joint destruction?
2. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis
3. Synovial macrophages
4. Quantitative analysis of cytokine gene expression in rheumatoid arthritis
5. Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis
6. Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joint
7. Role of cytokines in rheumatoid arthritis
8. Th1/Th2 cytokine balance in arthritis
9. High level of interleukin-10 produced by activated T cell population within the rheumatoid synovial membrane
10. Expression of interferon-gamma (IFN-gamma), IL-10, IL-12, and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA)
11. Inhibition of the population of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis
12. The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis
13. Cytokines and arthritis: Is the Th1/Th2 paradigm useful for understanding pathogenesis?
14. Nitric oxide synthase aspects concerning structure and catalysis
15. Nitric oxide synthases: Role, tolls, and controls
16. In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols
17. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin
18. Nitric oxide as S-nitrosoproteins in rheumatoid arthritis
19. Increased nitric oxide levels in patients with rheumatoid arthritis
20. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases
21. Detection of increased nitric oxide production in rheumatoid arthritis using the urinary nitrate/creatinine ratio
22. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide
23. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides
24. Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis
25. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients
26. The American Rheumatism Association 1987 revised criteria for the classification of the rheumatoid arthritis
27. IL-1β, a strong mediator for glucose uptake by rheumatoid and non rheumatoid cultured human synoviocytes
28. Improved methods to measure end products of nitric oxide in biological fluids: Nitrite, nitrate, and S-nitrosothiols
29. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production
30. Cell-mediated biotransformation of S-nitrosoglutathione
31. Nitrosation and oxidation in the regulation of gene expression
32. S-nitrosylation regulates apoptosis
33. Fas-induced caspase denitrosylation
34. Nitric oxide production in cells derived from the human joint
35. Induction of nitric oxide synthase in human chondrocytes
36. Nitric oxide synthesis and its regulation by rabbit synoviocytes
37. T-cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset
38. Nitrosative capacity of macrophage is dependent on nitric-oxide synthase induction signals
39. Suppression of arthritis by an inhibitor of nitric oxide synthase
40. Hemoglobin protects from streptococcal cell wall-induced arthritis
41. Macrophage deactivating factor and transforming growth factors-β1, -β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ
42. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor-β
43. Involvement of a transforming-growth-factor-β-like molecule in tumor-cell-derived inhibition of nitric oxide synthesis in cerebral endothelial cells
44. Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines
45. Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals
46. A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages
47. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4
48. Inhibition of inducible nitric oxide synthase expression by interleukin-4 and interleukin-13 in human lung epithelial cells
49. Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis
50. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction
51. Interleukin 10 cooperates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells
52. Mechanism of suppression of macrophage nitric oxide release by IL-13: Influence of the macrophage population
53. Interleukin-13 alters the activation state of murine macrophages in vitro: Comparison with interleukin-4 and interferon-gamma
54. Interleukin-13 inhibits inductible nitric oxide synthase expression in human mesengial cells
55. Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis
56. Interleukin-13 is a more potent inhibitor of the expression of inducible nitric oxide synthase in smooth muscle cells than in macrophages: A comparison with interleukin-4 and interleukin-10
57. Effects of Th1 and Th2 cytokines on cytokine production and ICAM-1 expression on synovial fibroblasts